BioReference Laboratories, Inc. Announces Quarterly and Yearly Record Revenues, Net Income and Patient Volumes
December 18, 2014 08:30 ET
|
Bio-Reference Laboratories, Inc.
ELMWOOD PARK, N.J., Dec. 18, 2014 (GLOBE NEWSWIRE) -- Bio-Reference Laboratories, Inc. (Nasdaq:BRLI) announces record fourth quarter and full fiscal year results for revenues, net income and patient...
BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2014
December 11, 2014 08:30 ET
|
Bio-Reference Laboratories, Inc.
ELMWOOD PARK, N.J., Dec. 11, 2014 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc. (Nasdaq:BRLI) announced today it plans to issue earnings results for the fourth quarter and year end for 2014...
BioReference Laboratories, Inc. Reports Record Quarterly Revenues and Patient Volumes for Third Quarter FY2014
August 27, 2014 08:30 ET
|
Bio-Reference Laboratories, Inc.
ELMWOOD PARK, N.J., Aug. 27, 2014 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc. (Nasdaq:BRLI) announces record third quarter results for revenues and patient volumes. Except for per share data...
BioReference Laboratories, Inc. Announces Earnings Date for Third Quarter Fiscal Year 2014
August 20, 2014 08:30 ET
|
Bio-Reference Laboratories, Inc.
ELMWOOD PARK, N.J., Aug. 20, 2014 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc. (Nasdaq:BRLI) announced today it plans to issue earnings results for the third quarter 2014 before the open of...
BioReference Laboratories, Inc. Reports Record Quarterly Revenues and Patient Volumes for Second Quarter FY2014
June 05, 2014 08:30 ET
|
Bio-Reference Laboratories, Inc.
ELMWOOD PARK, N.J., June 5, 2014 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc. (Nasdaq:BRLI) announces record second quarter results for revenues and patient volumes. Except for per share data...
BioReference Laboratories, Inc. Announces Earnings Date for Second Quarter Fiscal Year 2014
May 29, 2014 08:30 ET
|
Bio-Reference Laboratories, Inc.
ELMWOOD PARK, N.J., May 29, 2014 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc. (Nasdaq:BRLI) announced today it plans to issue earnings results for the second quarter 2014 before the open of...
Bio-Reference Laboratories, Inc. Announces That Robert Daber, Ph.D. Will Join Company as Director of R&D and Cancer Genetics
April 16, 2014 08:30 ET
|
Bio-Reference Laboratories, Inc.
ELMWOOD PARK, N.J., April 16, 2014 (GLOBE NEWSWIRE) -- Bio-Reference Laboratories, Inc. (Nasdaq:BRLI) announced today that it has hired Robert Daber, Ph.D. to assume the dual role as Director of...
Bio-Reference Laboratories, Inc. Reports Revenue Growth Despite Reimbursement Pressure and Impactful Weather
March 04, 2014 08:30 ET
|
Bio-Reference Laboratories, Inc.
ELMWOOD PARK, N.J., March 4, 2014 (GLOBE NEWSWIRE) -- Bio-Reference Laboratories, Inc. (Nasdaq:BRLI) announces record first quarter results for revenues. Except for per share data or where otherwise...
BioReference Laboratories, Inc. Announces Earnings Date for First Quarter Fiscal Year 2014
February 25, 2014 08:30 ET
|
Bio-Reference Laboratories, Inc.
ELMWOOD PARK, N.J., Feb. 25, 2014 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc. (Nasdaq:BRLI) announced today it plans to issue earnings results for the first quarter 2014 before the open of...
Bio-Reference Laboratories, Inc. Announces Record Quarterly Revenues and Record Annual Revenues and Earnings Despite Significant 4th Quarter Headwinds
December 19, 2013 08:30 ET
|
Bio-Reference Laboratories, Inc.
ELMWOOD PARK, N.J., Dec. 19, 2013 (GLOBE NEWSWIRE) -- Bio-Reference Laboratories, Inc. (Nasdaq:BRLI) announces best-ever quarterly results for revenues despite significant reimbursement changes noted...